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Changing and challenging times for
Canadian kidney health and disease
research
C. R. J. Kennedy1,2,3
“It was the best of times, it was the worst of times, it
was the age of wisdom, it was the age of foolishness, it
was the epoch of belief, it was the epoch of incredulity, it
was the season of Light, it was the season of Darkness, it
was the spring of hope, it was the winter of despair, we
had everything before us, we had nothing before us.”
Charles Dickens, A Tale of Two Cities
The issues
In many ways, the Canadian renal researcher lives in pri-
vileged times. Never before has she or he enjoyed such
remarkable access to the tools of the trade. Unprecedented
advances in biotechnology, genomics, molecular biology,
regenerative medicine, tissue banking, and computer
databases along with the implementation of numerous
infrastructure projects on a scale unparalleled in our
history have together luxuriously equipped our scientific
community. We stand poised for breakthroughs that will
significantly impact the renal health of Canadians both
tomorrow and well into the future. Thanks to initiatives
such as the federally funded Canada Foundation for
Innovation along with its provincial and local partners,
it is not uncommon for both basic and clinician scientists
specializing in nephrology to be employing state-of-the-art
equipment, housed in dozens of newly minted laboratories
and research buildings across our country. Moreover,
training programs such as the Kidney Foundation of
Canada (KFoC)/Canadian Institutes of Health Research
(CIHR) supported Kidney Research Scientist Core Educa-
tion and National Training Program (KRESCENT) initia-
tive have fostered the development of the next generation
of investigators, each eager to contribute to the advance-
ment of knowledge.
However, the times wherein the Canadian renal re-
searcher lives are also defined by enormous challenges.
Despite the wealth of research infrastructure and an
abundance of well-trained investigators, as in the USA,
our national research endeavor seems to have been de-
signed however, inadvertently, in anticipation of unlimited
growth. Over the past 15 years, universities, hospitals, and
research institutes have continued to hire into new po-
sitions in order to fill expanding wet and dry lab space
to capacity. Despite this increase in the hiring of principal
investigators, our system continues to train far more gradu-
ate students and postdoctoral fellows than there are posi-
tions in academia, industry, and government. Competition
for new investigator spots is fierce, forcing many individuals
to remain in training positions during their most creative
years until either obtaining their first independent position
or leaving research for other career options. These issues
have imposed stress upon the system and together with an
unchanging pool of funds available to investigators, have
driven down funding success for many individual research
operations.
Not long ago, CIHR funding levels hovered at the
20–27 % range; on some peer-review committees, this was
as high as 40 %, allowing for most applications ranked in
the excellent range (i.e., ≥4.0 on the CIHR scale) to be ap-
proved. Recent open operating grant competitions have
seen application pressure steadily increase, placing greater
burdens on both reviewers and their committees. This has
created a vicious cycle where highly ranked proposals line
up in the queue, often requiring several resubmissions be-
fore being funded, if at all. With the declining success
rates for CIHR applications, more applicants have sought
funding from other agencies, similarly driving up applica-
tion pressures and decreasing success rates. The net effect
has been that funding rates with most sources are now at
historic lows.
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Predictable, long-term funding for research projects has
proved increasingly difficult to sustain as these success
rates drop, often forcing labs to lose key staff in order to
endure down cycles. Moreover, the recent devaluation of
the Canadian versus American dollar has further destabi-
lized matters since many consumables are sourced from
the USA. Meanwhile, the capacity for extramural funding
agencies such as the Kidney Foundation of Canada, a
longtime supporter of renal research, has remained limited
over the past 15 years. Today’s CAD$50,000 per annum,
KFoC biomedical research grant has the purchasing power
equivalent to CAD$36,000 in the year 2000. The KFoC
is not the lone example however; fundraising efforts,
endowments and industry-based “no-strings-attached”
money have all suffered since the “Great Recession” of
2008. Despite widespread cuts to most departments,
the federal government has not reduced the level of
funding to the CIHR. Unfortunately, the relatively stag-
nant pool of research dollars has struggled to keep pace
with inflation in biomedical research. The net result of
these economic realities, coupled with an expanding
pool of investigators is that today’s renal scientist is
spending more of their time writing a greater number
of grant applications in a far more competitive environment
than their peers a generation ago—all at the expense of
carrying out actual research.
New funding structures
At the same time, the CIHR recently introduced signifi-
cant broad-based changes to how it evaluates and funds
scientific research. At the risk of understating the im-
pact, the revamped open suites programs (Foundation
and Project schemes) has generated a broad spectrum of
opinions among Canada’s scientific research community.
A formal critique of the new format would be premature
as the data have not yet been assembled, disseminated,
and interpreted. Moreover, this nascent system remains
fluid as it undergoes adjustments and amendments in re-
sponse to internal assessments as well as both applicant
and reviewer feedback. For example, it was welcome news
that the CIHR recently reversed its decision to only allow
applicants a single opportunity per calendar year to apply
for project grants. If this position had been maintained, re-
searchers’ ability to acquire funding in a timely manner
would have been severely limited.
For the renal research community, the new formats for
application and review need to be disseminated so that
kidney disease research maintains an appropriate level on
the Canadian science scene. Importantly, given the imple-
mentation of the college of reviewers, it is essential that
those within the renal research community offer their full
participation in the review process. The best minds in kid-
ney disease research should take their seats at the (virtual)
review table so that applications are evaluated by the most
appropriate experts who are intimately familiar with our
field. The same holds true for the updated KFoC Biomed-
ical Research Grant application format and its review
committee. Importantly, the question of whether these
new directions will adequately address the realities facing
our collective research endeavor remains unanswered.
Radical options?
Even with such dramatic changes to the funding mecha-
nisms at CIHR, are other options possible? Our American
colleagues are beginning to entertain far more radical
changes to their system. A grass roots movement is
emerging in the USA aimed at opening a dialogue between
scientists and institutions to challenge existing research
paradigms. The ideas were presented in two recent es-
says [1, 2]. The authors summarize the current plight
of scientific research in the US system and propose a
number of solutions. Perhaps surprisingly, a demand
for more money was not suggested, despite the recently
announced proposals by the House of Representatives
and Senate panels that would increase the NIH budget
by CAD$1.1–2 billion per year. They suggest training
fewer postdoctoral fellows and PhDs, with some of the
former being transitioned within labs to the so-called
super-doc positions. The idea is that these highly trained
individuals would graduate to staff-scientists, capable of
preserving the intra-laboratory memory and offering high
productivity levels [3]. There is even the idea that funding
agencies could mandate universities to direct a portion of
their overhead payments towards creating more of these
types of staff-scientist positions. Another proposal is to
cease supporting graduate students from NIH research
grants—relying instead on institutional training grants and
external scholarships.
Meanwhile the authors recommend that funding agencies
should be wary of “overfunding” labs since the law of
diminishing returns inevitably kicks in past a certain
threshold of research dollars. Such changes would re-
duce the number of “megalabs” while encouraging
smaller more sustainable operations—where principal
investigators would spend less time chasing research
dollars to fund operations. Moreover, the authors take
aim at the perceived trend towards translational research.
They state that “Overvaluing translational research is
detracting from an equivalent appreciation of fundamental
research of broad applicability, without obvious connec-
tions to medicine.” [1].
Lastly, the authors suggest that agencies should reward
projects that focus on originality and risk-taking to
discourage predictable, incremental research—which
inevitably arises when funding is difficult to obtain,
and research results are expected to be translated in the
short term to bear immediate fruit for society. What is
often lost is the value of the long view. Indeed, we value
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instant gratification and rapid return on investment.
In the past, many of Europe’s great cathedrals required
lengthy construction periods. The original architects
and builders were almost never worshipped in the finished
product. They held a long view of their work. Can the same
be said for the current Canadian research environment?
While tremendous value should be placed on carrying out
work that provides advances that are implemented in the
short term for the benefit of Canadians (e.g., Strategy
for Patient Oriented Research (SPOR), research aimed
at informing clinical practice guidelines, etc.), there are
some who feel that the balance in research structure is
tipping away from investigation that holds the long
view. Thus, scientists craft safer research proposals that
yield predictable findings thereby advancing their field
invariably in incremental steps.
Have you heard of Janelia Research Campus? It might
be the penultimate “long view” research institution. Origin-
ally named Janelia Farm, this is a free-standing research
campus of the Howard Hughes Medical Institute opened in
2006 (https://www.janelia.org/). It is decidedly atypical in
its structure and its operation philosophy. It was originated
to address some of the major issues facing the traditional
model of scientific research—namely an aversion to high-
risk endeavors and an inability to rapidly adapt research
programs to embrace opportunities that emerge with new
discoveries [4]. Researchers at Janelia Research Campus do
not write grants, and publication in peer-reviewed journals
is not viewed as the ultimate goal (although its scientists
routinely publish in very high-impact journals). In contrast
to the traditional research institute model where groups of
scientists with a wide variety of research interests are
assembled and divided into faculties, departments, and
programs, the developers of Janelia Farm limited the
field to two initial areas of scientific focus. The first was
the identification of principles that govern how informa-
tion is processed by neuronal circuits, using genetic model
systems in conjunction with imaging, electrophysiological,
and computational methods. The second was the develop-
ment of imaging approaches and computational methods
for image analysis. For the founders of Janelia, these areas
of research provided highly focused yet challenging project
themes that would benefit from “patient, generous funding
in an environment that fosters free-flowing dialogue,
critique, and creative problem solving across multiple
disciplines—an environment not easily created in current
research institutions” [4]. Taken together, the goal was
to assemble the best minds in these areas, let them “live
science” together on a daily basis, to not bother them
too much for a fairly long period of time, and see what
they come up with. Today, Janelia Research Campus
continues to build its research legacy, yet in accordance
with its long view, its impact will be judged by future
generations [5].
While radically transforming existing research struc-
tures along these lines sounds utopic and perhaps even
impractical for Canadian renal science, both the recent
dialogue about restructuring the research paradigm in
the USA and the Janelia Research Campus experiment
are instructive. For example, given our limited size and
capacity in Canada, would it be useful to ask fewer research
questions—to increase focus and enhance collaboration
among Canadian renal researchers? Similarly, should we
identify the key strengths of the Canadian nephrology re-
search community and accordingly, expand the number of
integrative teams to tackle these key questions? Or, should
we consider downsizing labs and consolidating resources
within existing institutions—supporting more shared staff-
scientists, and fewer students and postdocs? And lastly, in
terms of engaging with our funding agencies: we need to
participate fully in the new CIHR review process as well as
that of the KFoC in order to foster and support Canadian
research into kidney health and disease.
While the Dickens quote at the beginning of this edi-
torial may be viewed as hyperbole, in many ways, these
are indeed the best of times and the worst of times for
the wider renal research community in Canada. While
opportunities remain, challenges are many, for which we
await creative solutions.
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